Indeed, a recent study found drug-induced association of GRB2 with EGFR in multiple cancers harboring fusions of ALK, RET, NTRK1 and ROS1, including in patient samples of primary tumors, resistant tumors, and metastases13. This evidence concerns the gene ALK and cancer.